Dr. Arian Teymoorian, MD

Dr. Teymoorian practices at Endoscopy Center of Inland Empire in Murrieta, California.

Dr. Teymoorian's NPI, 1760822191, was assigned on June 29, 2013. Dr. Teymoorian graduated from St. George's University School of Medicine in 2013. Dr. Teymoorian holds California license A152257.

Dr. Teymoorian's primary practice is Endoscopy Center of Inland Empire, at 40404 California Oaks Road, Murrieta, CA 92562. The practice phone is (951) 304-0200.

Dr. Teymoorian's primary practice is Endoscopy Center of Inland Empire in Murrieta, California. Dr. Teymoorian is also affiliated with Loma Linda University Medical Center - Murrieta. The medical group on file is Inland Empire Gastroenterology (Inland Empire GI). Dmand AI also links Dr. Teymoorian to 2 more medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Teymoorian practices, 2 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Teymoorian's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Teymoorian is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Teymoorian's licenses on file in 6 states: California, New Mexico, Ohio, North Carolina, New York and Mississippi.

Dmand AI lists acid reflux, chronic inflammatory bowel disease (IBD), cirrhosis of the liver, colonoscopy, gastroenteritis, gastrointestinal bleeding, hemorrhoids and irritable bowel syndrome (IBS) among the conditions Dr. Teymoorian treats.

CMS data shows 518 Medicare services from Dr. Teymoorian across 12 procedure codes in 2024, for 314 Medicare patients. Medicare paid $64,175 for them.

CMS counts 314 Medicare patients who saw Dr. Teymoorian in 2024. The largest group is 65 to 74, with 161 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 15% are also on Medicaid. Their average risk score is 1.63, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Teymoorian's median patient age at 63, with 56% women.

In 2024, Dr. Teymoorian wrote 786 Medicare Part D claims for 331 patients. 76% of them were for generic drugs. CMS names the drug for 634 of them, across 19 drugs with 11 or more claims each, at $155,351 in total drug cost. In 2023, CMS named 622 claims across 16 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Dr. Teymoorian for performance year 2024, reported as part of a group. Dr. Teymoorian accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 100 procedures of colonoscopy by Dr. Teymoorian, more than 80% of the clinicians it reports for that procedure.

Dmand AI links 2 papers to Dr. Teymoorian in 2021. Dr. Teymoorian's most frequent co-authors are Logan Burstiner, DO and Kumar Pallav, MD.

CMS Open Payments shows 688 general payments to Dr. Teymoorian from 44 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 89% of the total. Abbvie Inc. paid the most, $4,830.

Dr. Teymoorian graduated from St. George's University School of Medicine in 2013.

Dr. Teymoorian is in network with 12 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.